Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

56 
 

Knowledge, Attitudes and Barriers Towards Breast Cancer Health Education Among 

Iraqi Community Pharmacists 

Hasan H. AL-Behadily*
,1 

and Haydar F.Al-Tukmagi
** 

*
 Ministry of Health/Environment, Baghdad, Iraq.

 

**
 Department of Clinical Pharmacy, College of Pharmacy, University of Baghdad, Baghdad, Iraq,  

Abstract 
With the increasing prevalence of breast cancer among female internationally, occupies about 25% of 

all cases of cancer, with a measured 1.57 million up to date cases in 2012. Breast cancer has turn a most warning 

to health of female in Iraq, where it is the major cause of death among women after cardiovascular diseases, 

with a mortality rate of 23% related cancer. Recently there is a crucial requirement to include community 

pharmacists in health elevation activities to support awareness and early diagnosis of cancer, specially breast 

cancer. The aim of this study is to assess knowledge, attitude and perceived barriers amongst Iraqi community 

pharmacists towards health promotion of breast cancer. This study is cross sectional research. A questionnaire 

was given to pharmacists. The questionnaire comprised from four parts: community pharmacist’s demographics 

and description of practice; knowledge of signs, symptoms and risk causes; knowledge around breast cancer 

screening and perceived barriers.300 questionnaires were finished and returned by Iraqi community 

pharmacists. Mean score of knowledge and screening of breast cancer was 7.9 ± 1.86 and 1.69± 0.33 points 

respectively, categorizing the overall knowledge and screening of breast cancer among participants as poor 

level, while mean score for pharmacist attitude was 26.44± 3.86   points, categorizing the overall attitude as 

favorable. Lack of time was perceived by a great proportion of pharmacists (68.2%) as a major barrier to 

providing patient education. 
Keywords: Breast cancer, Knowledge, Screening, Attitude, Perceived, Community pharmacy. 

 

 دراسة المعرفة والمىاقف والحىاجز لذي صيادلة المجتمع العراقييه حىل سرطان الثذي
ظ محمذ البهادليحسه حاف

,*1
و حيذر فخري التكمه جي  

** 

 

 
*

 . ، ثغذاد ، اىؼشاق وصاسح اىصحخ واىجُئخ
**

 فشع اىصُذىخ اىسشَشَخ ، ميُخ اىصُذىخ ، جبٍؼخ ثغذاد ، ثغذاد ، اىؼشاق .
 

 الخالصة 
حُش سجيذ ٍِ جَُغ حبالد اىسشطبُ،  %52حىاىٍ حُش َشنو، اىؼبىٍَػيً اىصؼُذ  اىْسبءٍغ رضاَذ اّزشبس سشطبُ اىثذٌ ثُِ 

اىشئُسٍ ىيىفبح ثُِ  تَؼزجش اىسجاىؼشاق، حُش  اىْسبء فٍمجُشا ىصحخ  رهذَذااىثذٌ  شنو سشطبُ . وقذ5175ٍيُىُ حبىخ حزً اُِ فٍ ػبً  7.21

اىَجزَغ  حبجخ ٍيحخ إلدساج صُبدىخْبك . فٍ اِوّخ األخُشح هحبالد اىسشطبُ ٪ 52ٍِثَؼذه وفُبد ، اىقيت واالوػُخ اىذٍىَخاىْسبء ثؼذ أٍشاض 

 ىزقٌُُ ٍؼشفخ وخجشح صُبدىخ اىهذف ٍِ هزٓ اىذساسخ هىاُ ، وخبصخ سشطبُ اىثذٌ. اىسشطبُ ٍجنشاورشخُص ىضَبدح اىىػٍ اىصحٍ وىذػٌ 

َزأىف االسزجُبُ ىيصُبدىخ. وحُش قذً قطؼُخ. ػجبسح ػِ ثحىس ٍهزٓ اىذساسخ   سشطبُ اىثذٌ. حىه ُِ واىَؼىقبد اىزٍ رىاجههٌاىَجزَغ اىؼشاقُ

ٍؼشفخ اىؼالٍبد واألػشاض وأسجبة اىخطش؛  اىََبسسبد اىَهُْخ؛يَجزَغ اىصُذىٍ ووصف أجضاء: اىىصف اىسنبٍّ ىاالسزجُبُ ٍِ أسثؼخ 

اىَجزَغ اىؼشاقٍ. ومبُ صُبدىخ  ٍِ قجوثؼذ رىل وقذ رٌ االّزهبء ٍِ االسزجُبّبد وإػبدرهب  اىَزىقؼخ. واىَؼىقبدواىَؼشفخ حىه فحص سشطبُ اىثذٌ 

رصُْف اىَؼشفخ اىشبٍيخ وفحص سشطبُ اىزىاىٍ، حُش رٌ ّقطخ ػيً  1.22 ± 7.17و 1..7±  1.7دسجخ ٍؼشفخ وفحص سشطبُ اىثذٌ ٍزىسط 

يً اّهب حُش رٌ رصُْفهب ػّقطخ،  1..2±  51.22دسجخ ٍىقف اىصُذىٍ ، فٍ حُِ مبُ ٍزىسط ظؼُفٍسزىي رو اىثذٌ ثُِ اىَشبسمُِ ػيً أّهب 

 .اىَشَط اٍبً رؼيٌُ٪( محبجض سئُسٍ 5..1قجو ّسجخ مجُشح ٍِ اىصُبدىخ ) ظُبع جضء مجُش ٍِ اىىقذ ٍِمبُ َْظش إىً  دسجخ ٍقجىىخ.
سرطان الثذي،المعرفة ، الفحص  ، المىقف ، االدراك ، صيادلة المجتمع .الكلمات المفتاحية:

Introduction   
Breast cancer is the most frequent cancer 

in the midst of women worldwide, occupies about 

25% of all cases of cancer, with a measured 1.57 

million up to date cases in 2012 
(1)

. Breast  cancer  

has turn a most warning  to  health  of  female  in 

Iraq , where  it is the major cause of death among 

women after cardiovascular system diseases, with a 

mortality rate of  23%  related cancer 
(1-4)

.  Early 

diagnosis through screening plays a vital role in 

reducing mortality and morbidity of breast cancer 
(5,6)

. Localized cancer diagnosis enhance survival, 

restore the breast, and declines the recurrence rate 
(7)

. The growing burden of breast cancer in the 
Eastern Mediterranean Region (EMR) in general, 

and Iraq in specially, focus the critical need to 

found full national control programs of cancer. 

  
1
Corresponding author E-mail: Hassanhafid@ymail.com 

 Received: 16/9/ 2017 

 Accepted:13 /10/2017  
 
 
 

mailto:Hassanhafid@ymail.com


Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

57 
 

Of the registered methods to breast cancer control, 

as planned by the World Health Organization 

(WHO), early diagnosis and screening suggestion 

the immediate goal for a decline in   mortality
 (8)

. 

The risk factors that may have a relation with the 

occurrence of breast cancer are late age menopause, 

young age at menarche, late age at first live birth, 

use of oral contraceptives, hormone replacement 

therapy, high weight, extreme alcohol intake, and 

radiation exposure 
(9)

. Healthcare professionals are 

important sponsors in helping breast cancer 

awareness amongst their publics 
(10,11)

. Recently, 

the range of practice of pharmacy had developed to 

a patient-focused method rather than a product 

motivated method, allowing pharmacists to enlarge 

health services to patient-oriented actions in its 

place of traditional drug services 
(12,13)

. Previous 

reports shown that community pharmacists are 

probable providers to health promotion actions 

attractive into attention their accessibility and 

reliability 
(12-15)

. As readily  available  health care 

specialists, pharmacists can evaluate breast cancer 

risk and possibly advantage large numbers of 

female, irrespective of age. Pharmacists, in 

combination with physicians, can offer  knowledge  

to  permit  women  to create educated choices  

about  screening and prevention 
(16)

. Pharmacists 

can tell women of their breast cancer threat and let 

them to work collected with all participants of the 

health care group to make balanced choices. Patient 

teaching relating to breast cancer awareness and 

diagnosis through Breast self-examination (BSE), 

Clinical breast examination (CBE), and 

mammography is significant 
(5,17,18,19)

. 

Nevertheless, inadequate number of texts evaluated 

the role of community pharmacists in educating 

public awareness about cancer disease, highlighting 

on early diagnosis and screening 
(20 - 22)

. Thus, there 

is a crucial requirement to include community 

pharmacists in health elevation activities to support 

awareness and early diagnosis of   cancer, specially 

breast cancer. To reach this, it is necessary for 

community pharmacists to have widespread 

knowledge, progressive attitudes, willingness and 

essential tools to deliver specialized pharmaceutical 

care services 
(12,20,23,24)

. The aim of this study is to 

assess knowledge, attitude and perceived barriers 

amongst Iraqi community pharmacists towards 

health promotion of breast cancer. 

Methods 
The study was conducted over an 8-month 

period from December 2016 to July 2017. Of 375 

questionnaires given to Iraqi pharmacists, 300 

questionnaires were finished and returned, resulting 

a response rate of 80%. A descriptive cross-

sectional research design was applied to this study. 

A structured questionnaire was established and 

modified from questionnaires used in previous 

studies 
(25-27)

. The study was approved by scientific 

committee of college of pharmacy – Baghdad 

University. Suitability sampling was taken to 

employee pharmacists in multiple geographical 

areas in Baghdad City (Capital of Iraq). 

Participants who have bachelor’s degree in 

pharmacy or a higher educational degree were 

permitted to contribute in this research. This 

method is thought to reach a great answer rate of 

contribution. The questionnaire was established in 

English language and was given to pharmacists. 

The survey firstly evaluated by use Face and 

content validity by different faculty memberships 

at college of pharmacy – Baghdad University. 

Significance and survey questions clarity were 

further assessed through a pilot study (n = 30). 

Feedback and comments by the pilot group resulted 

in minor edits to the survey tool, which was 

considered in order to increase clarity and 

understanding of survey items. The sample data 

from pilot study were excluded from the final 

study. The study presented composed of 21 

questions to be finished in 15–20 minute. The 

questionnaire comprised from four parts: (1) 

community pharmacist’s demographics and 

description of practice (2) knowledge around breast 

cancer signs, symptoms and risk causes; (3) 

knowledge around breast cancer screening and (4) 

perceived barriers to supporting breast cancer 

awareness and providing pharmaceutical care in 

community pharmacy locations. Pharmacists 

answered to a 15-item scale around breast cancer 

risk factors in addition to signs and symptoms of 

the cancer. Answers fluctuated between ‘Correct’, 

‘Incorrect’ and ‘I don’t know’. Then, each 

‘Correct’ answer was counted 1 point and each 

‘Incorrect’ and ‘I don’t know’ answers were both 

counted zero (0) point. The total level ranged from 

0 to 15 points on overall knowledge of breast 

cancer. Pharmacists with level range 0–8 were 

measured to have poor level of knowledge of breast 

cancer risk causes and symptoms, while those with 

9–15 points were considered to have an acceptable 

level of knowledge. Knowledge around breast 

cancer screening was evaluated over seven 

different questions established by researchers based 

on recently published guidelines and 

recommendations by American Cancer Society 

(ACS) for screening and early detection of cancer 
(27)

. The total level ranged 0–7 points. In the same 

way, answers to screening knowledge questions 

were spread between ‘Correct’, ‘Incorrect’ and ‘I 

don’t know’. Knowledge of screening was divided 

into ‘poor’ if participants counted (0–3) points or 

‘satisfactory’ if the level reached between 4 and 7 

points. Attitudes to breast cancer screening were 

calculated by a 7-item Likert type attitudinal scale 

with five-point answers ranging from strongly 

agree to strongly disagree. The total attitude level 

ranged from 0 to 28 points, where higher values 

suggest more satisfactory attitude amongst 

participants. In this study, the internal reliability 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

58 
 

coefficient (Cronbach’s a) measured for attitude 

items was 0.734. Analysis of data was done using 
IBM SPSS statistical package (IBM Corp. Version 

21.0. Armonk, NY, USA).  By using descriptive 

statistics   to report study variables. Pearson’s chi-

square (v2) test of independence was used to exam 

for correlations between categorical variables. 

Bivariate correlation analysis was done to test for 

correlations between continuous variables. 

Variances were considered to be statistically 

significant at P< 0.05. 

Results 
Demographics and description of practice 

Demographics and practice features of 

community pharmacists are represented in Table 1. 

The average age of answering pharmacists was 

29.27 ± 3.165 years (median = 28.50 years) with a 

range from 24 to 41 years. Majority of participants 

were male pharmacists (54%) and were under 30 

years (63.7%). 235 (78.3%) of pharmacists have 

bachelor degree while 65 of them (21.7%) have 

postgraduate degree. Nearly half of the pharmacists 

surveyed [148 pharmacists (49.3 %)] stated that 

pharmacy technicians were one at one shift of 

work. Pharmacists’ view about oncology education 

in the undergraduate degree presented that [114 

pharmacists (38.0%)] agreed to receive adequate 

education, while 68 of pharmacists (22.7%) 

disagreed and 118 of pharmacists (39.3%) 

providing a neutral response. 170 (56.7%) of 

pharmacists answered yes around the oral 

anticancer agents that dispensed in the community 

pharmacy while 128 (42.7%) and 2 (0.7%) 

answered no and I don’t know respectively. 
 

Knowledge about breast cancer risk factors and 

early symptoms among community pharmacists: 
Most of community pharmacists [ 208 

pharmacists (69.3%)] agreed to the fact that breast 

cancer is the most usually diagnosed type of cancer 

among women worldwide. When asked if breast 

cancer should not be of concern for patient younger 

than 40 years, 152 (50.7%) of pharmacists agreed 

that this statement was incorrect. 171 (57.0%) of 

pharmacists agreed that approximately 50--70 % of 

patients with primary or metastatic breast cancer 

have hormone receptor --positive cancer. 

Regarding the initial signs and symptoms of breast 

cancer, more than half of pharmacists [169 

pharmacists (56.3%)] agreed that a painless lump is 

the initial sign. Questioning about findings in 

advanced breast cancer 174 (58.0%) of respondents 

agreed that pain, nipple discharge and skin edema 

are common findings in this stage. Additional 

results are demonstrated in Table 2. In order to 

evaluate the knowledge of prompting factors to 

breast cancer risk, responses were assessed in form 

of level out of 15 points. Mean score was 7.9 ± 

1.86 points (median = 8, range 1–15), categorizing 

the overall knowledge of breast cancer among 

participants as poor level of knowledge of breast 

cancer risk factors and symptoms. Overall 

assessment of pharmacists’ knowledge shown that 

half the pharmacists (50%) had poor knowledge, 

while the other half had satisfactory level of 

knowledge of breast cancer. Nearly 172 

pharmacists (57.3%) agreed that average-risk 

women should consider mammography at age of 40 

and yearly thereafter. The overall mean score for 

pharmacists’ knowledge of screening strategies was 

1.69± 0.33 out of a maximum score of 7 points 

(median = 2, range 0–7) categorizing the 

knowledge as poor. Additional screening data are 

shown in Table 3. 

Description of attitudes towards breast cancer 

health promotion among community pharmacists 

Community pharmacist’s attitude about 

involvement in breast cancer health activities is 

represented in Table 4. 117 of pharmacists (39.0%) 

strongly agreed that pharmacists should be 

involved in breast cancer health promotion in 

community pharmacy settings. In addition, more 

than 200 pharmacists either agreed or strongly 

agreed that it is the pharmacist’s responsibility to 

provide breast cancer counselling to patients. Mean 

score for pharmacist attitude was 26.44± 3.86 out 

of a maximum score of 28 points (median = 27, 

range 4–28), categorizing the overall attitude as 

favorable. 

Perceived barriers towards breast cancer health 

promotion among community pharmacists  

Perceived barriers to breast cancer health 

activities amongst community pharmacists are 

shown in Figure 1. Lack of time was perceived by a 

great proportion of pharmacists (68.2%) as a major 

barrier to providing patient education. Other greatly 

documented barriers were lack of skills (65.2%), 

lack of privacy (64.9%) and lack of educational 

materials (60.3%). A small percentage of 

pharmacists (30.5%) stated lack of direct profit as a 

barrier to involvement in patient education. 

Relationship of demographics and characteristics 

of practice with knowledge and attitudes towards 

breast cancer health promotion among 

community pharmacists 
Bivariate correlation analysis of 

continuous variables (represented in table 5) 

showed that age had no significant association with 

overall knowledge of breast cancer (r = - 0.021, P = 

0.360), knowledge of  breast cancer screening (r = -

0.098, P = 0.045) or attitude (r = - 0.010, P = 

0.434) among pharmacists. Instead, there was a 

significant positive association between 

pharmacist’s knowledge of breast cancer and 

knowledge of breast cancer screening (r = 0.285, P 

= 0.000).  



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

59 
 

Table (1 ):Demographic and practice characteristics (N = 300) 

 

Characteristic n (%) 

Age (years)  

<30 

30—40 

40—50 

>50 

 

191 (63.7) 

104 (35.6) 

2 (.7) 

-------  

Gender 

Male 

Female 

 

162 (54.0) 

138 (46.0) 

Marital status of pharmacist 

single 

Married 

Divorced 

Widowed 

 

148 (49.3) 

146 (48.7) 

5 (1.7) 

1 (0.3) 

Education of pharmacist 

Bachelor 

Postgraduate Degree 

 

235 (78.3) 

65 (21.7) 

Place of graduation 

Local 

Public 

Private 

 

83 (27.7) 

172 (57.3) 

45 (15.0) 

Number of years of practice 

<3 

 

3—5 

6—10 

11—20 

>20 

 

 

143 (47.7)) 

95 (31.6) 

61 (20.3) 

1 (.3) 

Types of pharmacy 

Chain 

Independent 

 

64 (21.3) 

236 (78.7) 

Description of practice 

Staff pharmacist 

Pharmacist in charge 

Owner 

 

79 (26.3) 

90 (30.0) 

131 (43.7) 

 

 

 

 

 

 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

60 
 

Continued table (1)  

 

Employment Status 

Full time 

Part time 

 

54 (18.0) 

246 (82.0) 

Average number of adult patients seen in pharmacy in one shift 

<20 

20—59 

60—80 

>80 

 

 

64 (21.3) 

177 (59) 

52 (17.3) 

7 (2.3) 

Percentage of female patients seen in the pharmacy at one shift 

<25 

25—50 

51—75 

>75 

 

 

100 (33.3) 

168 (56) 

32 (10.7) 

---------- 

Number of pharmacists working in the pharmacy at one shift 

1 

2 

3 

 

227 (75.7) 

61 (20.3) 

12 (4.0) 

Number of pharmacy technicians in the pharmacy at any one shift 

None 

1 

2 

>2 

 

91 (30.3) 

148 (49.3) 

49 (16.3) 

12 (4.0) 

Dispensing of oral anticancer agents in the community pharmacy 

Yes 

No 

I don’t know 

 

170 (56.7) 

128 (42.7) 

2 (.7) 

Family history of cancer disease 

Yes 

No 

I don’t know 

 

97 (32.3) 

176 (58.7) 

27 (9.0) 

Received educate oncology education in the undergraduate degree 

Agree 

Disagree 

Neutral 

 

114 (38.0) 

68 (22.7) 

118 (39.3) 

values are expressed as n (%). 

 

 

 

 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

61 
 

Table (2) :Knowledge of breast cancer signs and symptoms among participants (N =300)  

 

Table ( 3):Participants’ performance on breast cancer screening guidelines (N = 300) 

values are expressed as n (%). 

 

 

 

 

Breast cancer knowledge item n ( % ) 

Correct Incorrect I don’t know 

Breast cancer is the commonly diagnosed form of 

cancer among women worldwide (correct ) 

208 ( 69.3) 54 (18.0 ) 38 (12.7 ) 

Breast cancer should not be of concern for 

patients younger than 40 of age ( Incorrect ) 

121 (40.3) 152 (50.7) 27 (9.0) 

Approximately 50--70 % of patients with primary 

or metastatic breast cancer have hormone receptor 

--positive tumor ( correct ) 

171 (57.0) 77 (25.7) 52 (17.3) 

A painless lump is the initial sign of breast cancer 

in most women ( correct ) 

169 (56.3) 80 (26.70 51 (17.0) 

Pain , nipple discharge , retraction , or dimpling , 

skin edema , redness , or warmth are common 

findings in breast cancer patients advanced stages 

( correct ) 

174 (58.0) 82 (27.3) 44 (14.7) 

Breast cancer screening item n ( % ) 

Correct Incorrect I don’t 

know 

Women should be counseled about the importance to start breast 

self-examination (BSE) starting at 30 years of age ( Incorrect ) 

129 (43.0) 135 (45.0) 36 (12.0) 

If a women chooses to do breast self-examination ( BSE) , it is 

recommended to be done on monthly basis ( Correct ) 

166 (55.3) 94 (31.3) 40 (13.3) 

Limitation of BSE include the possibility of a false-- positive 

result ( Correct ) 

163 (54.3) 86 (28.7) 51 (17.0) 

A symptomatic women aged 40 years or older should not receive 

CBE as part of their periodic health examination ( Correct ) 

136 (45.3) 101 (33.7) 63 (21.0) 

Average-- risk women should begin annual mammography at of 

40 years ( correct ) 

172 (57.3) 82 (27.3) 46 (15.3) 

There is no need to continue mammography after 50 years of age 

as a regular tool for the early detection of breast cancer ( Incorrect 

) 

98 (32.7) 142 (47.3) 60 (20.0) 

Mammography will not detect all breast cancers , and some breast 

cancers detected with mammography may still have a poor 

prognosis ( Correct ) 

139 (46.3) 104 (34.7) 57 (19.0) 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

62 
 

Table (4) :Attitude of pharmacists regarding breast cancer health promotion (N = 300)  

values are expressed as n (%). 
 

Table (5 ):Correlation analysis for continuous variables (N = 300) 

 

Age mean of 

pharmacists 

(years) 

 

29.27 

Knowledge mean 

of breast cancer 

 

Knowledge mean 

of screening 

 

Attitude mean of pharmacists 

 

 

Mean              r             P 

 

7.8967        - 0.021        0.360 

 

Mean            r           P 

 

1.6905       -0.098         0.045 

Mean              r               P 

 

26.4400      - 0.010        0.434 

--------- 

---------- 

 

 

 

 

Mean of knowledge                              Mean of screening                  r                 P  

 

7.8967                                                         1.6905                          0.285         0.000  

 

 
 
 
 
 
 
 

Statement n ( % ) 

Strongly 

agree 

Agree Neutral Disagree Strongly 

disagree 

Pharmacists should be involved 

in breast cancer health promotion 

in the pharmacy 

117 (39.0) 140 (46.7) 22 (7.3) 3 (1.0) 18 (6.0) 

It is my responsibility as a 

pharmacist to provide breast 

cancer counseling , and this can 

improve my professional status 

and satisfaction 

102 (34.0) 127 (42.3) 36  (12.0) 19 (6.3) 16 (5.3) 

As a community pharmacist, I 

feel  confident and prepared to 

provide breast cancer health 

promotion 

94 (31.3) 138 (46.0) 31 (10.3) 20 (6.7) 17 (5.7) 

Distributing breast cancer 

education materials is important 

in community pharmacy settings 

77 (25.7) 137 (45.7) 33 (11.0) 34 (11.3) 19 (6.3) 

It is important to discuss breast 

cancer with my female patients 

to encourage breast cancer early 

screening and detection 

97 (32.3) 117 (39.0) 27 (9.0) 25 (8.3) 34 (11.3) 

Patients demand to get 

counseling on breast cancer 

screening and early detection 

from the community pharmacist 

76 (25.3) 81 (27.0) 53 (17.7) 46 (15.3) 44 (14.7) 

Patients appreciate efforts of 

community pharmacists when 

counselled about breast cancer 

120 (40.0) 76 (25.3) 33 (11.0) 35 (11.7) 36 (12.0) 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

63 
 

 

 
Figure ( 1 ):Barriers for breast cancer health as 

stated by community pharmacists. Bars 

represent the percentage of community 

pharmacists agreeing to the barriers listed on 

the X-axis (N = 300). 

 

Discussion 
The purposes of this study were to 

evaluate knowledge, attitudes and barriers of 

community pharmacists to breast cancer health 

educational services in Iraq. The  findings key of 

this study showed that the  most  of  community  

pharmacists lack enough knowledge of breast 

cancer and new screening references. Numerous 

reports from   developing countries showed that 

breast cancer level of awareness  about  breast  

cancer  and  performance of  screening  was  little  

amongst  female  population 
(28,29)

. Pharmacists are 

reachable healthcare specialists who are in direct 

contact with the public for long hours every day. 

Recently, pharmacists are suitable progressively 

involved in a range of health care screenings and 

protecting services 
(12, 13, 30)

. The consequences of 

this study established that community pharmacists 

in Iraq hope to take an important role in breast 

cancer health promotion amongst the public. Low 

level of knowledge of breast cancer screening 

references amongst community pharmacists in Iraq 

can be described, in part, by lacking occurrence of 

continuous education plans and insufficient 

undergraduate teaching. Though, these results 

established a vital need for continuing education 

plans intended for community pharmacists in order 

to be well-prepared to offer active breast cancer 

health education. It is also essential to study and 

expand oncology education in undergraduate 

pharmacy developments to attain the aims of 

improved health promotion roles for graduating 

pharmacists. In our study the overall attitude 

considered as favorable where community 

pharmacists perceived breast cancer counselling as 

a responsibility and a vital subject to discuss with 

their female patients. It is important to increase the 

community awareness of the health care services 

providing by community pharmacists through 

helpful hard work of community pharmacies with 

pharmaceutical families. Previous instructions from 

developed countries showed that attitude and 

coordination of healthcare providers are significant 

determining factor for public participation in breast 

cancer screening programs 
(31 ,32)

. In their report in 

2001, Giles et al. have assessed the results of a 

community pharmacy-based breast cancer 

awareness programmed, representing significant 

enhancements in rate of women carrying out self-

examination subsequent pharmacist-based 

intervention 
(33)

. In this reading, Iraqi pharmacists 

showed lack of time as the key barrier to breast 

cancer health promotion. where, community 

pharmacists are participating greater quantity of 

time in dispensing activities rather than given that 

patient education and health information. This 

universal barrier to substantial pharmacist 

educational performance can be overwhelmed by 

employing pharmacy technicians to bearing routine 

dispensing actions, thus provided that more time 

for patient-oriented services by registered 

pharmacists. Other probable decisions to overcome 

time barriers would be to representative, with 

organization, most routine dispensing activities to 

pharmacist assistance, thus pharmacists might have 

additional time to offer pharmaceutical care 
(34,35)

. 

Absence of educational material was also observed 

as a barrier to breast tumor education by 

pharmacists in this study. For active patient 

education, community pharmacists should be 

providing with essential apparatuses, such as 

printed material, which can be simply providing to 

community in work locations.  Compared with 

Qatar study earlier evaluation for involvement  in  

breast  cancer  health  education was conducted 

among community pharmacists in Qatar 
(20)

. 

Similar to our study, assessment of breast cancer 

awareness among community pharmacists in Qatar 

showed some knowledge limitations. The study 

among pharmacists in Qatar indicated insufficient 

knowledge particularly for questions related to 

breast cancer risk factors and screening 

recommendations 
(20)

. Community pharmacists in 

Qatar showed positive attitudes to be involved in 

breast cancer education. Lack of personnel, time 

and privacy were considered major barriers among 

community pharmacists in Qatar
(20)

. The results of 

our study showed a positive association between 

pharmacist’s knowledge of breast cancer and 

knowledge of breast cancer screening were 

associated with favorable attitude towards 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

64 
 

involvement in breast cancer education among 

pharmacists. 
 

Conclusion 
In this survey we found that Iraqi 

community pharmacists have low level of 

knowledge about sign, symptoms and risk factor of 

breast cancer, in addition to knowledge of 

screening. However, the community pharmacists 

wish to increased their knowledge toward breast 

cancer.  This improvement in knowledge of 

community pharmacy will be effective educators of 

the population about breast cancer.   

References 
1. International Agency for Research on Cancer: 

Globocan 2012. Lyon, France, World Health 

Or- ganization International Agency for 

Research on Cancer, 2013 

2. Alwan NAS. Breast cancer: Demographic 
characteristics and clinico-pathological 

presentation of patients in Iraq. East Mediterr 

Health J 2010;16:1159-1164.  

3. Iraqi Cancer Board. Results of the Iraqi Cancer 
Registry 2012.Baghdad, Iraq, Iraqi Cancer 

Registry Center, Ministry of Health, 2015. 

4. Al Alwan NA. DNA proliferative index as a 
marker in Iraqi aneuploid mammary 

carcinoma. East Mediterr Health J 

2000;6:1062-1072.  

5. Greenwald P, Nasca PC, Lawrence CE, et al. 
Estimated effect of breast self-examination and 

routine physician examinations on breast-

cancer mortality. N Engl J Med 

1978;299(6):271–3. 

6.  Smart CR, Hendrix RE, Rutledge JH, et al. 
Benefit of mammography screening in women 

ages 40–49. Cancer 1995;75(7):1619–26. 

7. Forbes JF. The incidence of breast cancer: the 
global burden, public health considerations. 

Semin Oncol 1997;24(1) S1: 20–35. 

8. Towards a strategy for cancer control in the 
Eastern Mediterranean Region, 1st ed. Cairo, 

World Health Organization Regional Office 

for the Eastern Mediterranean, 2010. 

9. Mutebi M, Wasike R, Mushtaq A, et al. The 
effectiveness of an abbreviated training 

program for health workers in breast cancer 

awareness: innovative strategies for resource 

constrained environments. Springerplus 2013; 

2: 528. 

10. National Institutes of Health. What you need to 
know about breast cancer. Washington, DC: 

National Cancer Institute, 1995. 

11. Daudt A, Alberg AJ, Helzlsouer KJ. 
Epidemiology, prevention, and early detection 

of breast cancer. Curr Opin Oncol 

1996;8(6):455–61. 

12. Calis KA, Hutchison LC, Elliott ME, et al. 
Healthy People 2010: challenges, 

opportunities, and a call to action for 

America’s pharmacists. Pharmacotherapy 

2004; 24: 1241–1294. 

13. Anderson S. Community pharmacy and public 
health in Great Britain, 1936 to 2006: how a 

phoenix rose from the ashes. J Epidemiology 

Community Health 2007; 61: 844–848. 

14. Hourihan F, Krass I, Chen T. Rural community 
pharmacy: a feasible site for a health 

promotion and screening service for 

cardiovascular risk factors. Aust J Rural 

Health 2003; 11: 28–35.  

15. Ciardulli LM, Goode JV. Using health 
observances to promote wellness in 

community pharmacies. J Am Pharm Assoc 

2003; 43: 61–68. 

16. Armstrong K, Eisen A, Weder B. Assessing 
the risk of breast cancer. N Engl J Med 

2000;342(8):564–71. 

17. Hill D, White V, Jolley D, et al. Self-
examination of the breast: is it beneficial? 

Meta-analysis of studies investigating breast 

self-examination and extent of disease in 

patients with breast cancer. Br Med J 

1988;297(6643):271–5. 

18. Foster RS Jr, Lang SP, Costanza MC, et al. 
Breast self-examination practices and breast-

cancer stage. N Engl J Med 1978;299(6):265–

70. 

19. Baines CJ. Breast self-examination. Cancer 
1992;69(S7): 1942–6. 

20. El Hajj MS, Hamid Y. Breast cancer health 
promotion in Qatar: a survey of community 

pharmacists’ interests and needs. Int J Clin 

Pharm 2011; 33: 70–79. 

21. Beshir SA, Hanipah MA. Knowledge, 
perception, practice and barriers of breast 

cancer health promotion activities among 

community pharmacists in two Districts of 

Selangor state, Malaysia. Asian Pac J Cancer 

Prev 2012; 13: 4427–4430. 

22. Kachroo S. Pharmacists should assume a 
larger role in overcoming the racial/ethnic 

barriers to breast cancer screening. J Manag 

Care Pharm 2006; 12: 406–407. 

23. Holle LM, Boehnke Michaud L. Oncology 
pharmacists in health care delivery: vital 

members of the cancer care team. J Oncol 

Pract 2014; 10: 142–145. 

24. Liekweg A,Westfeld M, Jaehde U . From 
oncology pharmacy to pharmaceutical care: 

new contributions to multidisciplinary cancer 

care. Support Care Cancer 2004; 12: 73–79. 

25. Alkhasawneh IM. Knowledge and practice of 
breast cancer screening among Jordanian 

nurses. Oncol Nurs Forum 2007; 34: 1211–

1217. 

26. Alkhasawneh IM, Akhu-Zaheya LM, Suleiman 
SM. Jordanian nurses’ knowledge and practice 

of breast self-examination. J Adv Nurs 2009; 

65: 412–416. 



Iraqi J Pharm Sci, Vol.26(2) 2017                                                   Knowledge, attitudes and barriers towards breast cancer 

65 
 

27. Madanat H, Merrill RM. Breast cancer risk-
factor and screening awareness among women 

nurses and teachers in Amman, Jordan. Cancer 

Nurs 2002; 25: 276–282. 

28. Abu-Helalah MA, Al-Shraideh HA, Al-Serhan 
AH, et al. Knowledge, barriers and attitudes 

towards breast cancer mammography 

screening in jordan. Asian Pac J Cancer Prev 

2015; 16: 3981–3990. 

29. Suleiman AK. Awareness and attitudes 
regarding breast cancer and breast self-

examination among female Jordanian students. 

J Basic Clin Pharm 2014; 5: 74–78. 

30. Hassali M, Awaisu A, Shafie AA, et al. 
Professional training and roles of community 

pharmacists in Malaysia: views from general 

medical practitioners. Malays Fam Physician 

2009; 4: 71–76. 

31. Ibrahim NA, Odusanya OO. Knowledge of 
risk factors, beliefs and practices of female 

healthcare professionals towards breast cancer 

in a tertiary institution in Lagos, Nigeria. BMC 

Cancer 2009; 9: 76. 

32. Akhigbe AO, Omuemu VO. Knowledge, 
attitudes and practice of breast cancer 

screening among female health workers in a 

Nigerian urban city. BMC Cancer 2009; 9: 

203. 

33. Giles JT, Kennedy DT, Dunn EC, et al. 
Results of a community pharmacy-based 

breast cancer risk-assessment and education 

program. Pharmacotherapy 2001; 21: 243–253. 

34. Awad A, Waheedi M. Community 
pharmacist’s role in obesity treatment in 

Kuwait: a cross-sectional study. BMC Public 

Health 2012; 12: 863. 

35. Ghazal RM, Hassan NA, Al-Ahdab OG, et al. 
Barriers to the implementation of 

pharmaceutical care into the UAE community 

pharmacies. IOSR J Pharm 2014; 4: 68–74.